Guardant Health
GH
#1121
Rank
NZ$37.43 B
Marketcap
NZ$276.72
Share price
-2.17%
Change (1 day)
59.50%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2023 (TTM): NZ-$8.11

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is NZ-$6.22. In 2022 the company made an earnings per share (EPS) of NZ-$11.40 a decrease over its 2021 EPS that were of NZ-$7.13.

EPS history for Guardant Health from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$8.11-28.83%
2022NZ-$11.4060%
2021NZ-$7.1355.04%
2020NZ-$4.60207.14%
2019NZ-$1.50-19.81%
2018NZ-$1.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
NZ-$0.45-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
NZ-$4.36-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA